Sean Teng, Jie Wang, Collin D. Sroge, Jan Abendroth, Donald D. Lorimer, Peter S. Horanyi, Thomas E. Edwards, Logan Tillery, Justin K. Craig, Wesley C. Van Voorhis, Peter J. Myler, Craig L. Smith
{"title":"Crystal structure of the S-adenosylmethionine-dependent mycolic acid synthase UmaA from Mycobacterium tuberculosis","authors":"Sean Teng, Jie Wang, Collin D. Sroge, Jan Abendroth, Donald D. Lorimer, Peter S. Horanyi, Thomas E. Edwards, Logan Tillery, Justin K. Craig, Wesley C. Van Voorhis, Peter J. Myler, Craig L. Smith","doi":"10.1107/S2053230X25001530","DOIUrl":null,"url":null,"abstract":"<p><i>Mycobacterium tuberculosis</i> is a Gram-positive bacillus that causes tuberculosis and is a leading cause of mortality worldwide. This disease is a growing health threat due to the occurrence of multidrug resistance. Mycolic acids are essential for generating cell walls and their modification is important to the virulence and persistence of <i>M. tuberculosis.</i> A family of <i>S</i>-adenosylmethionine-dependent mycolic acid synthases modify mycolic acids and represent promising drug targets. UmaA is currently the least-understood member of this family. This paper describes the crystal structure of UmaA. UmaA is a monomer composed of two domains: a structurally conserved SAM-binding domain and a variable substrate-binding auxiliary domain. Fortuitously, our structure contains a nitrate in the active site, a structural mimic of carbonate, which is a known general base in cyclopropane-adding synthases. Further investigation indicated that the structure of the N-terminus is highly flexible. Finally, we have identified <i>S</i>-adenosyl-<i>N</i>-decyl-aminoethyl as a promising potential inhibitor.</p>","PeriodicalId":7029,"journal":{"name":"Acta crystallographica. Section F, Structural biology communications","volume":"81 4","pages":"146-154"},"PeriodicalIF":1.1000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta crystallographica. Section F, Structural biology communications","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1107/S2053230X25001530","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Mycobacterium tuberculosis is a Gram-positive bacillus that causes tuberculosis and is a leading cause of mortality worldwide. This disease is a growing health threat due to the occurrence of multidrug resistance. Mycolic acids are essential for generating cell walls and their modification is important to the virulence and persistence of M. tuberculosis. A family of S-adenosylmethionine-dependent mycolic acid synthases modify mycolic acids and represent promising drug targets. UmaA is currently the least-understood member of this family. This paper describes the crystal structure of UmaA. UmaA is a monomer composed of two domains: a structurally conserved SAM-binding domain and a variable substrate-binding auxiliary domain. Fortuitously, our structure contains a nitrate in the active site, a structural mimic of carbonate, which is a known general base in cyclopropane-adding synthases. Further investigation indicated that the structure of the N-terminus is highly flexible. Finally, we have identified S-adenosyl-N-decyl-aminoethyl as a promising potential inhibitor.
结核分枝杆菌是一种引起结核病的革兰氏阳性杆菌,是全世界死亡的主要原因。由于多药耐药的发生,该病已成为日益严重的健康威胁。霉菌酸是产生细胞壁所必需的,它们的修饰对结核分枝杆菌的毒力和持久性至关重要。s -腺苷甲硫氨酸依赖的霉菌酸合成酶家族修饰霉菌酸,并代表有希望的药物靶点。UmaA目前是这个家族中最不为人所知的成员。本文描述了UmaA的晶体结构。UmaA是由两个结构域组成的单体:一个结构保守的sam结合结构域和一个可变的底物结合辅助结构域。幸运的是,我们的结构在活性位点含有硝酸盐,这是一种碳酸盐的结构模拟物,碳酸盐是环丙烷加合酶中已知的一般碱。进一步的研究表明,n端结构具有高度的柔韧性。最后,我们发现s -腺苷- n -癸基-氨基乙基是一种很有潜力的抑制剂。
期刊介绍:
Acta Crystallographica Section F is a rapid structural biology communications journal.
Articles on any aspect of structural biology, including structures determined using high-throughput methods or from iterative studies such as those used in the pharmaceutical industry, are welcomed by the journal.
The journal offers the option of open access, and all communications benefit from unlimited free use of colour illustrations and no page charges. Authors are encouraged to submit multimedia content for publication with their articles.
Acta Cryst. F has a dedicated online tool called publBio that is designed to make the preparation and submission of articles easier for authors.